ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0175

Correlation of Subclinical Synovitis with Juvenile Idiopathic Arthritis Outcome Measurements

Patricia Vega-Fernandez1, Edward Oberle2, Michael Henrickson1, Jennifer Huggins1, Mekibib Altaye3, Amy Cassedy4, Johannes Roth5 and Tracy Ting1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Nationwide Children's Hospital, Columbus, OH, 3Cincinnati Children's Hospital, Cincinnati, OH, 4Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 5University of Ottawa, Ottawa, ON, Canada

Meeting: ACR Convergence 2021

Keywords: Pediatric rheumatology, subclinical disease, Ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Title: Imaging of Rheumatic Diseases Poster (0149–0182)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is the most common rheumatologic disease of childhood. Active joint count (AJC) is one of the key JIA Core Set variables. However, AJC is a subjective measurement with poor-to-moderate inter-rater agreement. Musculoskeletal Ultrasound (MSUS) is a radiation-free, objective imaging tool currently being used to assess joint inflammation. A novel joint-specific MSUS scoring system for JIA was recently proposed[1]. The aims of this study are: 1. Determine the frequency of subclinical synovitis as per MSUS in all peripheral joints in JIA, 2. Correlate AJC as determined by expert clinician physical examination with moderate to severe MSUS synovitis, 3. Examine the correlation between MSUS synovitis and Juvenile Arthritis Disease Activity Score (JADAS) and patient-reported outcomes

Methods: Data obtained from a previously described study looking to determine the key joints to perform a MSUS examination in JIA[1] was used for the current analysis. Briefly, JIA patients presenting with an AJC >4 and able to perform MSUS within 1 week of starting a Disease-modifying Antirheumatic Drug were eligible for this study. Clinical data including physician global assessment (PhGA), patient global assessment (PGA), patient pain visual analogue scale (VAS) and the Child Health Assessment Questionnaire (CHAQ) were obtained. A comprehensive AJC examination and a 42 joint MSUS examination by an American College of Rheumatology MSUS certified pediatric rheumatologist were performed at baseline and at 3 months. Gray-scale B mode and Power Doppler (PD) images were obtained for each view. Images were scored following a semiquantitative scoring system ranging from 0-normal to 3-severe. Subclinical synovitis was defined as grade 2 and 3 synovitis appreciated by MSUS only. Clinical-JADAS 10 (cJADAS-10) was calculated by the addition of PhGA, PGA, and AJC up to 10 joints. Pearson correlation was used to assess the correlation between AJC and subclinical synovitis. Spearman’s correlation coefficients were calculated to determine the association between MSUS synovitis, cJADAS-10 and patient-reported outcomes

Results: A total of 30 patients were enrolled. Table 1 shows the frequency of subclinical synovitis per joint. In general, MSUS detects moderate to severe synovitis in about 25% of the joints determined as normal by physical exam. Except for the knee where the correlation between MSUS synovitis and AJC was moderate, the correlation between MSUS and AJC for all other peripheral joints was slight to fair (Table 2). MSUS synovitis and patient reported outcomes including CHAQ, patient pain VAS and PGA had slight to fair correlation for B-Mode and moderate correlation for PD. Correlation between MSUS and cJADAS-10 was moderate for both B Mode and PD images. (Table 3)

Conclusion: Subclinical synovitis is commonly observed in a cohort of newly diagnosed JIA patients with greatest differences in digits. The fair to moderate correlation of MSUS synovitis with cJADAS-10 and patient-reported outcomes, suggest that MSUS assesses a different, possibly more objective, domain not determined by traditional JIA outcome measurements. MSUS has the potential to support the diagnosis and assessment of JIA


Disclosures: P. Vega-Fernandez, None; E. Oberle, None; M. Henrickson, None; J. Huggins, None; M. Altaye, None; A. Cassedy, None; J. Roth, None; T. Ting, None.

To cite this abstract in AMA style:

Vega-Fernandez P, Oberle E, Henrickson M, Huggins J, Altaye M, Cassedy A, Roth J, Ting T. Correlation of Subclinical Synovitis with Juvenile Idiopathic Arthritis Outcome Measurements [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/correlation-of-subclinical-synovitis-with-juvenile-idiopathic-arthritis-outcome-measurements/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-of-subclinical-synovitis-with-juvenile-idiopathic-arthritis-outcome-measurements/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology